Ethyl 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetate, 97%, 250mg

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95%, 10g

Bis(4-tert-butylphenyl)iodonium Tetrafluoroborate>98.0%(HPLC)1g

2-Bromo-4,5-dimethoxyphenylacetonitrile, 95.0%, 5g

8-Bromooctanoic Acid>97.0%(T)25g

Cadralazine, 98%, 250mg

1-(3-Fluoropyridin-2-yl)cyclopropane-1-carboxylic acid, 5g

(3S,4S)-4-Fluoropyrrolidin-3-ol hydrochloride, 97%, 10g

(4-(Trifluoromethyl)phenyl)methanamine hydrochloride, 95.0%, 100mg

N-(4-(tert-Butyl)thiazol-2-yl)-3-fluorobenzamide, 97%, 1g

(3-(Thiomorpholine-4-carbonyl)phenyl)boronic acid, 97%, 250mg

2-((Tert-butoxycarbonyl)amino)-3-(4-(trifluoromethoxy)phenyl)propanoic acid, 95%, 1g

FMOC-VAL-OH-15N, 95.0%, 250mg